122 related articles for article (PubMed ID: 33203521)
1. A Contemporary Analysis of the 30-day Morbidity and Mortality Associated With Cytoreductive Nephrectomy.
May DN; Hill H; Matrana MR; Lata-Arias K; Canter DJ
Urology; 2021 Jan; 147():186-191. PubMed ID: 33203521
[TBL] [Abstract][Full Text] [Related]
2. Perioperative outcomes of cytoreductive nephrectomy in the UK in 2012.
Jackson BL; Fowler S; Williams ST;
BJU Int; 2015 Dec; 116(6):905-10. PubMed ID: 25098910
[TBL] [Abstract][Full Text] [Related]
3. Morbidity and Mortality of Radical Nephrectomy for Patients With Disseminated Cancer: An Analysis of the National Surgical Quality Improvement Program Database.
Wallis CJ; Bjarnason G; Byrne J; Cheung DC; Hoffman A; Kulkarni GS; Nathens AB; Nam RK; Satkunasivam R
Urology; 2016 Sep; 95():95-102. PubMed ID: 27292566
[TBL] [Abstract][Full Text] [Related]
4. Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma.
Roussel E; Campi R; Larcher A; Verbiest A; Antonelli A; Palumbo C; Derweesh I; Ghali F; Bradshaw A; Meagher MF; Heck M; Amiel T; Kriegmair MC; Rubio J; Musquera M; D'Anna M; Autorino R; Guruli G; Veccia A; Linares-Espinos E; Van Bruwaene S; Hevia V; Porpiglia F; Checcucci E; Minervini A; Mari A; Pavan N; Claps F; Marchioni M; Capitanio U; Beuselinck B; Mir MC; Albersen M;
Eur Urol Oncol; 2020 Aug; 3(4):523-529. PubMed ID: 32414697
[TBL] [Abstract][Full Text] [Related]
5. Perioperative Morbidity of Open Versus Minimally Invasive Partial Nephrectomy: A Contemporary Analysis of the National Surgical Quality Improvement Program.
Pereira J; Renzulli J; Pareek G; Moreira D; Guo R; Zhang Z; Amin A; Mega A; Golijanin D; Gershman B
J Endourol; 2018 Feb; 32(2):116-123. PubMed ID: 29121786
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive Nephrectomy.
Gershman B; Moreira DM; Boorjian SA; Lohse CM; Cheville JC; Costello BA; Leibovich BC; Thompson RH
Eur Urol; 2016 Jan; 69(1):84-91. PubMed ID: 26044802
[TBL] [Abstract][Full Text] [Related]
7. Contemporary Perioperative Morbidity and Mortality Rates of Minimally Invasive
Khalil MI; Ubeda J; Soehner T; Bhandari NR; Payakachat N; Davis R; Raheem OA; Kamel MH
J Endourol; 2019 Nov; 33(11):920-927. PubMed ID: 31333072
[No Abstract] [Full Text] [Related]
8. Predicted versus observed 30-day perioperative outcomes using the ACS NSQIP surgical risk calculator in patients undergoing partial nephrectomy for renal cell carcinoma.
Blair BM; Lehman EB; Jafri SM; Kaag MG; Raman JD
Int Urol Nephrol; 2018 Jul; 50(7):1249-1256. PubMed ID: 29868938
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of the timing of surgical complications following nephrectomy: data from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP).
Sood A; Abdollah F; Sammon JD; Kapoor V; Rogers CG; Jeong W; Klett DE; Hanske J; Meyer CP; Peabody JO; Menon M; Trinh QD
World J Urol; 2015 Dec; 33(12):2031-8. PubMed ID: 25910477
[TBL] [Abstract][Full Text] [Related]
10. Morbidity and mortality of multivisceral resection with radical nephrectomy for locally advanced renal cell carcinoma: An analysis of the National Surgical Quality Improvement Program (NSQIP) database.
Lim K; Riveros C; Ranganathan S; Xu J; Patel A; Slawin J; Ordonez A; Aghazadeh M; Morgan M; Miles BJ; Esnaola N; Klaassen Z; Allenson K; Brooks M; Wallis CJD; Satkunasivam R
Urol Oncol; 2023 Apr; 41(4):209.e1-209.e9. PubMed ID: 36801191
[TBL] [Abstract][Full Text] [Related]
11. Improved survival after cytoreductive nephrectomy for metastatic renal cell carcinoma in the contemporary immunotherapy era: An analysis of the National Cancer Database.
Singla N; Hutchinson RC; Ghandour RA; Freifeld Y; Fang D; Sagalowsky AI; Lotan Y; Bagrodia A; Margulis V; Hammers HJ; Woldu SL
Urol Oncol; 2020 Jun; 38(6):604.e9-604.e17. PubMed ID: 32253116
[TBL] [Abstract][Full Text] [Related]
12. Contemporary Patients Have Better Perioperative Outcomes Following Cytoreductive Nephrectomy: A Multi-institutional Analysis of 1272 Consecutive Patients.
Esdaille AR; Karam JA; Master VA; Spiess PE; Raman JD; Sharma P; Shapiro DD; Das A; Sexton WJ; Zemp L; Patil D; Allen GO; Matin SF; Wood CG; Abel EJ
Urology; 2023 Dec; 182():168-174. PubMed ID: 37690543
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for the development of postoperative complications in patients with metastatic kidney cancer treated with cytoreductive nephrectomy.
Hernández-Pañeda H; Garza-Gangemi AM; Manzanilla-Romero HH; Hernández-Gaytán CA; Gabilondo-Navarro F; Rodríguez-Covarrubias F
Cir Cir; 2021; 89(5):632-637. PubMed ID: 34665165
[TBL] [Abstract][Full Text] [Related]
14. Effect of the Need for Preoperative Dialysis on Perioperative Outcomes on Patients Undergoing Laparoscopic Nephrectomy: An Analysis of the National Surgical Quality Improvement Program Database.
May D; Khaled D; Matrana MR; Bardot SF; Lata-Arias K; Canter D
Urology; 2019 Feb; 124():154-159. PubMed ID: 30448368
[TBL] [Abstract][Full Text] [Related]
15. Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
Schmitges J; Trinh QD; Sun M; Hansen J; Bianchi M; Jeldres C; Perrotte P; Dahlem R; Shariat SF; Chun FK; Montorsi F; Menon M; Fisch M; Graefen M; Karakiewicz PI
BJU Int; 2012 Sep; 110(6 Pt B):E183-90. PubMed ID: 22321256
[TBL] [Abstract][Full Text] [Related]
16. Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients.
Palumbo C; Knipper S; Dzyuba-Negrean C; Pecoraro A; Rosiello G; Tian Z; Shariat SF; Simeone C; Briganti A; Saad F; Berruti A; Antonelli A; Karakiewicz PI
J Geriatr Oncol; 2020 May; 11(4):718-723. PubMed ID: 31257163
[TBL] [Abstract][Full Text] [Related]
17. Predicting Complications Following Robot-Assisted Partial Nephrectomy with the ACS NSQIP
Winoker JS; Paulucci DJ; Anastos H; Waingankar N; Abaza R; Eun DD; Bhandari A; Hemal AK; Sfakianos JP; Badani KK
J Urol; 2017 Oct; 198(4):803-809. PubMed ID: 28400189
[TBL] [Abstract][Full Text] [Related]
18. Thirty-day readmission and reoperation after surgery for spinal tumors: a National Surgical Quality Improvement Program analysis.
Karhade AV; Vasudeva VS; Dasenbrock HH; Lu Y; Gormley WB; Groff MW; Chi JH; Smith TR
Neurosurg Focus; 2016 Aug; 41(2):E5. PubMed ID: 27476847
[TBL] [Abstract][Full Text] [Related]
19. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma.
Bhindi B; Abel EJ; Albiges L; Bensalah K; Boorjian SA; Daneshmand S; Karam JA; Mason RJ; Powles T; Bex A
Eur Urol; 2019 Jan; 75(1):111-128. PubMed ID: 30467042
[TBL] [Abstract][Full Text] [Related]
20. Hospital volume and short-term outcomes after cytoreductive nephrectomy.
Xia L; Strother MC; Taylor BL; Chelluri RR; Pulido JE; Guzzo TJ
J Surg Oncol; 2018 Jun; 117(7):1589-1596. PubMed ID: 29575038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
